[go: up one dir, main page]

MD1652G2 - Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină - Google Patents

Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină Download PDF

Info

Publication number
MD1652G2
MD1652G2 MD97-0099A MD970099A MD1652G2 MD 1652 G2 MD1652 G2 MD 1652G2 MD 970099 A MD970099 A MD 970099A MD 1652 G2 MD1652 G2 MD 1652G2
Authority
MD
Moldova
Prior art keywords
leu
protein
ala
gly
lys
Prior art date
Application number
MD97-0099A
Other languages
English (en)
Russian (ru)
Other versions
MD1652F2 (ro
MD970099A (ro
Inventor
Daniel Caput
Pascual Ferrara
Jean-Claude Guillemot
Mourad Kaghad
Christine Labit-Le Bouteiller
Pascal Leplatois
Marilyn Magazin
Adrian Minty
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9103904A external-priority patent/FR2674537B1/fr
Priority claimed from FR9200137A external-priority patent/FR2685919B1/fr
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of MD970099A publication Critical patent/MD970099A/ro
Publication of MD1652F2 publication Critical patent/MD1652F2/ro
Publication of MD1652G2 publication Critical patent/MD1652G2/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5446—IL-16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5437—IL-13
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F02—COMBUSTION ENGINES; HOT-GAS OR COMBUSTION-PRODUCT ENGINE PLANTS
    • F02B—INTERNAL-COMBUSTION PISTON ENGINES; COMBUSTION ENGINES IN GENERAL
    • F02B75/00—Other engines
    • F02B75/02—Engines characterised by their cycles, e.g. six-stroke
    • F02B2075/022—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle
    • F02B2075/027—Engines characterised by their cycles, e.g. six-stroke having less than six strokes per cycle four

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Invenţia se referă la o proteină cu activitate de tip citochină sau la precursorul acestei proteine, care conţine următoarea succesiune a aminoacizilor (a1):Gly Pro Val Pro Pro Ser Thr Ala Leu Arg Glu Leu Ile Glu Glu LeuVal Trp Ser Ile Asn Leu Thr Ala Xaa Met Tyr Cys Ala Ala Leu GluSer Leu Ile Asn Val Ser Gly Cys Ser Ala Ile Glu Lys Thr Gln ArgMet Leu Ser Gly Phe Cys Pro His Lys Val Ser Ala Gly Gln Phe SerSer Leu His Val Arg Asp Thr Lys Ile Glu Val Ala Gln Phe Val Lys85\tab\tab\tab90\tab\tab 95Asp Leu Leu Leu His Leu Lys Lys Leu Phe Arg Glu Gly Arg Phe Asn100\tab\tab 105\tab\tab 110în care Xaa reprezintă Asp sau Gly.Invenţia se referă de asemenea la ADN recombinant, codificator pentru această proteină, la celule şi microorganisme transformate, la vector de expresie, precum şi la un procedeu de obţinere a proteinei şi remediu cu acţiune imunomodulatoare.
MD97-0099A 1991-03-29 1992-03-27 Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină MD1652G2 (ro)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9103904A FR2674537B1 (fr) 1991-03-29 1991-03-29 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.
FR9200137A FR2685919B1 (fr) 1992-01-08 1992-01-08 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules animales transformees.
PCT/FR1992/000280 WO1992017586A1 (fr) 1991-03-29 1992-03-27 Proteine a activite de type cytokine, adn recombinant codant pour cette proteine, cellules et micro-organismes transformes

Publications (3)

Publication Number Publication Date
MD970099A MD970099A (ro) 1998-04-30
MD1652F2 MD1652F2 (ro) 2001-04-30
MD1652G2 true MD1652G2 (ro) 2001-12-31

Family

ID=26228598

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0099A MD1652G2 (ro) 1991-03-29 1992-03-27 Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină

Country Status (14)

Country Link
US (1) US5652123A (ro)
EP (1) EP0506574B1 (ro)
JP (1) JP2865423B2 (ro)
AT (1) ATE130869T1 (ro)
CA (1) CA2083826C (ro)
DE (2) DE69206301T2 (ro)
DK (1) DK0506574T3 (ro)
ES (1) ES2054601T3 (ro)
GR (2) GR940300052T1 (ro)
HK (1) HK1007435A1 (ro)
HU (2) HU217099B (ro)
IE (1) IE72165B1 (ro)
MD (1) MD1652G2 (ro)
WO (1) WO1992017586A1 (ro)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596072A (en) * 1992-08-21 1997-01-21 Schering Corporation Method of refolding human IL-13
JPH07508179A (ja) * 1992-08-21 1995-09-14 シェリング・コーポレーション ヒトインターロイキン−１３
US6274711B1 (en) 1993-06-14 2001-08-14 Inserm, Institut National De La Sante Et De La Recherche Medicale Purified mammalian CTLA-8 antigens and related reagents
CN1094975C (zh) * 1995-02-10 2002-11-27 诺沃奇梅兹有限公司 芽胞杆菌属蛋白酶
EP0809693B1 (en) * 1995-02-10 2005-11-30 Novozymes A/S Bacillus proteases
US6576232B1 (en) * 1998-04-03 2003-06-10 The Penn State Research Foundation IL13 mutants
US7553487B2 (en) 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
DK1141286T3 (da) 1998-12-14 2007-02-19 Genetics Inst Llc Kæde af cytokinreceptorer
WO2001077332A2 (en) 2000-04-07 2001-10-18 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors
US20070104710A1 (en) * 2002-06-28 2007-05-10 Domants Limited Ligand that has binding specificity for IL-4 and/or IL-13
US20110223168A1 (en) * 2002-12-27 2011-09-15 Greg Winter Ligand that has binding specificity for il-4 and/or il-13
US20050059024A1 (en) * 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
CN102993302B (zh) 2003-12-23 2016-01-20 遗传技术研究公司 抗il-13抗体及其应用
US7501121B2 (en) 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
AR049390A1 (es) 2004-06-09 2006-07-26 Wyeth Corp Anticuerpos contra la interleuquina-13 humana y usos de los mismos
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
ATE492563T1 (de) 2004-11-17 2011-01-15 Amgen Inc Vollständige humane monoklonale antikörper gegen il-13
US20080044420A1 (en) * 2005-05-11 2008-02-21 Heavner George A Anti-IL-13 antibodies, compositions, methods and uses
KR101363777B1 (ko) 2005-09-30 2014-02-14 메디뮨 리미티드 인터루킨―１３ 항체 조성물
RU2472807C2 (ru) 2006-09-08 2013-01-20 Эбботт Лэборетриз Интерлейкин-13-связывающие белки
BRPI0810561A2 (pt) * 2007-04-23 2019-09-24 Wyeth Corp métodos e composições para tratar e monitorar tratamento de desordens associadas à il-13.
JP2012506695A (ja) * 2008-08-20 2012-03-22 ヤンセン バイオテツク，インコーポレーテツド 改変された抗ｉｌ−１３抗体、組成物、方法、及び使用
GB0904214D0 (en) * 2009-03-11 2009-04-22 Ucb Pharma Sa Biological products
FR2957799B1 (fr) 2010-03-26 2012-08-17 Inst Des Vaisseaux Et Du Sang Compositions proangiogeniques, leur procede de preparation et leurs utilisations
PL3044323T3 (pl) 2013-09-13 2022-06-27 F.Hoffmann-La Roche Ag Sposoby wykrywania i ilościowego oznaczania białka komórki gospodarza w liniach komórkowych
AU2014318615B2 (en) 2013-09-13 2020-03-12 Genentech, Inc. Methods and compositions comprising purified recombinant polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL92685A0 (en) * 1988-12-16 1990-09-17 Us Commerce Dna encoding lymphokine/cytokine like proteins,cells transformed thereby and production of said proteins and antibodies against them

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Chang H.C. et al. Eur. J. Imm., 1989, vol. 19, p. 1045-1051 *
Cochran B.M. et al. Cell., 1983, vol. 33, p. 939-947 *
Matsushima K. et al. J. Exp. Med., 1988, vol. 167, p. 1883-1893 *
Peppel K. et al. J. Exp. Med., 1991, vol. 173, p. 349-355 *
Thompson et al. Proc. Natl. Acad. Sci., 1989, vol. 86, p.1333-1337 *
Ullman K.S. et al. Ann. Rev. Imm., 1989, vol. 8, p. 421-452 *
Von Heijne G. Nucl. Ac. Res., 1986, vol. 14, p. 4683-4690 *
Weiser W. Y. et al. Proc. Natl. Acad. Sci. USA, 1989, vol. 86, p. 7522-7526 *

Also Published As

Publication number Publication date
GR3019043T3 (en) 1996-05-31
HUT68162A (en) 1995-05-29
ES2054601T3 (es) 1996-04-01
EP0506574A1 (fr) 1992-09-30
DE69206301D1 (de) 1996-01-11
JP2865423B2 (ja) 1999-03-08
CA2083826C (en) 1999-04-27
DE506574T1 (de) 1994-11-17
GR940300052T1 (en) 1994-08-31
HK1007435A1 (en) 1999-04-09
CA2083826A1 (en) 1992-09-30
MD1652F2 (ro) 2001-04-30
JPH06500567A (ja) 1994-01-20
WO1992017586A1 (fr) 1992-10-15
MD970099A (ro) 1998-04-30
HU217099B (hu) 1999-11-29
IE72165B1 (en) 1997-03-26
ES2054601T1 (es) 1994-08-16
US5652123A (en) 1997-07-29
DK0506574T3 (da) 1996-04-09
HU9203753D0 (en) 1993-03-29
IE921016A1 (en) 1992-10-07
DE69206301T2 (de) 1996-06-13
EP0506574B1 (fr) 1995-11-29
ATE130869T1 (de) 1995-12-15

Similar Documents

Publication Publication Date Title
MD1652G2 (ro) Proteină cu activitate de tip citochină, ADN recombinant, codificator pentru această proteină, celule şi microorganisme transformate, vector de expresie, procedeu de obţinere a proteinei şi remediu care conţine această proteină
CA2050300A1 (en) Tnf-inhibiting proteins and the preparation thereof
AU1633200A (en) Human parathyroid hormone modifications, preparation and use
IL104314A0 (en) Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them
ATE386118T1 (de) Cnp-gen und vorläuferprotein aus schwein
NZ333606A (en) Isolated peptides derived from MAGE-2
AU5963290A (en) Inhibition of the n-end rule pathway in living cells
DE3261304D1 (en) Retro-inverso analogues of c-terminal penta and hexapeptides of substance p.
CA2083837A1 (en) Recombinant dna coding for a novel protein having .beta.-1,3 glucanase activity, bacteria containing this dna, transformed plant cells and plants
MY104909A (en) Peptide compounds.
ES2056753A6 (es) Un procedimiento para la produccion de un polipeptido que tiene actividad de factor quemotactico de monocitos humanos.
CA2077590A1 (en) Recombinant dna coding for a protein with endochitinase activity
NZ334714A (en) Liver proteins as agents against autoimmune diseases
NO975565L (no) Benstimulerende faktor
AU585167B2 (en) Novel substrate peptides
SE8603546L (sv) Polypeptider och framstellningsforfarande derav
AU8302791A (en) Recombinant gene coding for a protein having an endochitinase activity
IL74703A (en) Process for the preparation of peptides and some tripeptides as intermediates therefor
HUP9702500A2 (hu) Elhízás elleni proteinek
EP0853484A4 (en) NEW LIGANDS OF MU OPIOID RECEPTORS: AGONISTS AND ANTAGONISTS
Takahashi et al. The amino acid sequence of ribonuclease U1, a guanine-specific ribonuclease from the fungus Ustilago sphaerogena
CA2024279A1 (en) Recombinant c-terminal –-amidating enzyme of human thyroid origin
WO1997012036A3 (en) Bone stimulating factor
WO1999057262A3 (de) An metallionen bindendes peptid
PT100299A (pt) Analogo de hirudina, metodo para a sua producao e anti-coagulante contendo-o, e vector de secrecao , microorganismos transformados com o referido vector e metodo para a producao de produtos a partir dos referidos microorganismos

Legal Events

Date Code Title Description
PD99 Pending application
MK4A Patent for invention expired